Skip to content
Search

Latest Stories

RPS responds to DHSC’s consultation on smokefree generation and youth vaping

RPS responds to DHSC’s consultation on smokefree generation and youth vaping

All tobacco products, cigarette papers and herbal smoking products should be covered in the new legislation, says RPS  

The Royal Pharmaceutical Society (RPS) has said that it strongly supports the UK government’s proposal that individuals born on or after 1 January 2009 should be prohibited from legally purchasing tobacco products.


It has also shown its agreement to several other actions proposed by the Department of Health and Social Care's (DHSC) for ‘Creating a Smokefree Generation and Tackling Youth Vaping’ including:

  • The inclusion of all tobacco products, cigarette papers, and herbal smoking products in the new legislation.
  • Restrictions on the sale and supply of disposable vapes, and vape flavours.

RPS President, Professor Claire Anderson, said: "Our recommendations reflect a commitment to creating a future free from the harms of tobacco and youth vaping. It's crucial to prohibit access for the youngest generation, regulate all tobacco-related items, and address the allure of flavoured e-cigarettes.”

The organisation said that it has outlined the key recommendations to address the pressing issue of youth vaping and tobacco consumption, drawing on its e-cigarette policy and the expertise of its Science and Research committee.

Restrict sale for tobacco products to adolescents  

RPS explained that the age of sale for tobacco products should be changed to prohibit adolescents from legally purchasing the products, as “the adolescent phase, spanning from 12 to 18 years in humans, emerges as a particularly vulnerable period for the maturation of brain circuits governing cognition and emotion, rendering it susceptible to the impacts of nicotine and tobacco.”

“Prolonged exposure to nicotine during adolescence triggers noteworthy alterations in neurochemistry and behaviour,” it said.

Further, it stated that individuals who refrain from initiating smoking during adolescence are “statistically less inclined to take up smoking later in life.”

Proxy sales should also be prohibited

RPS also opined that anyone born before 1 January 2009 should be prohibited from purchasing tobacco products on behalf of anyone born on or after 1 January 2009 because “they increase accessibility and exposure of adolescents to tobacco.”

“Prohibiting the proxy sale of tobacco-containing products to adolescents aligns with a broader commitment to promoting public health, preventing addiction, and ensuring the wellrounded development of young individuals during a crucial stage of their lives,” it explained.

The organisation believes that including all tobacco products, including cigarettes, smokeless tobacco, and herbal smoking alternatives, in the new legislation, will ensure “uniform protection against the harmful effects associated with the use of these products.”

“This approach prevents potential loopholes that could be exploited by the relevant industry to market alternative products to adolescents,” it said.

Restrict vape flavours

The RPS agreed that the UK Government and devolved administrations should restrict vape flavours, and suggested that limiting the characterising flavours (the taste and smell) of vapes would be the most effective way to do so.

To check use of vape flavours in children and young people, they recommended restricting flavours to tobacco only, as it “eliminates the appeal of sweet and fruity flavours that often attract young people to start vaping.”

Additionally, it outlined the need for restrictions on the sale and supply of disposable vapes, particularly those that are not rechargeable, not refillable, or neither rechargeable nor refillable.

“Restricting the sale of non-rechargeable and non-refillable vapes aligns with broader environmental sustainability goals. Disposable vapes contribute significantly to environmental harm due to their single-use nature. The batteries and materials used in these devices can pose challenges for proper disposal and recycling,” it said.

The RPS is also in favour of the inclusion of non-nicotine e-liquid, for example shortfills, in restrictions on vape flavours.

Moreover, it opined that vapes shouldn’t be allowed to be displayed at the point of sale, like tobacco products, to limit the exposure of children.

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less